Iconic Worldwide receives FDA approval to sell nitrile gloves in the US

From left: Iconic Medicare Sdn Bhd chief marketing officer Tan Cho Chuan, Iconic Worldwide Bhd executive officer Jason Chung Wei Chiun, Iconic Worldwide Bhd managing director Datuk Tan Kean Tet, Iconic Worldwide Bhd executive officer Tan Seok Ying, Iconic Worldwide Bhd executive officer Tan Cho Chia and Iconic Medicare Sdn Bhd chief procurement officer Tan Seok Fang.

KUALA LUMPUR: Iconic Worldwide Bhd has received approval to sell its nitrile examination powder-free gloves in the United States.

In a statement, Iconic said its wholly-owned subsidiary Iconic Medicare Sdn Bhd obtained the 510(k) premarket notification clearance from the US Food and Drug Administration (FDA) to market and sell nitrile examination powder-free gloves.

With the 510(K) clearance received on Dec 14, 2021, Iconic said it would now be able to distribute its medical-grade gloves throughout the US.

“The FDA clearance is timely as we have just started operations in our new PPE manufacturing facility for gloves and medical face masks here in Batu Kawan, Penang. According to the Malaysian Rubber Glove Manufacturers Association, the global demand for gloves is expected to hit 420 billion pieces next year.

“Our aim is to manufacture at least 5% of the total global glove demand within 5 years, targeting export markets such as US & Europe,” Iconic managing director Datuk Tan Kean Tet.

In addition, the Group has also obtained CE and ISO certifications for its nitrile gloves and medical face masks, all of which will enable the group to export its products worldwide.

“In the third and fourth quarters of the current financial year, we will ship out 500 million pieces of rubber gloves to the United States, Europe, Africa, Middle-East and South-East Asia. This will be in time for us to materialise it in our financial year 2022 accounts,” Tan said.